tirzepatide and alcohol consumption Groundbreaking studies indicate Semaglutide may reduce in individuals with obesity Mounjaro and Alcohol: Is Drinking

A 17% Reduction in Overall Cancer Risk A landmark study published in JAMA Oncology (Dai H et al., August 2025), drawing on data from 14 health systems encompassing approximately 20 million patients, found that adults with obesity who were prescribed GLP-1 receptor agonists had a 17% lower risk of developing cancer compared to carefully matched non-users

GLP-1 (glucagon-like peptide-1) is a hormone released from specialized cells (L-cells) primarily in the gut in response to eating

You do not need to explain your medication to servers

After 3-4 weeks : Many people find that the aches begin to lessen as their body gets used to the medication